Matches in SemOpenAlex for { <https://semopenalex.org/work/W2509183933> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2509183933 endingPage "8" @default.
- W2509183933 startingPage "33" @default.
- W2509183933 abstract "Calcipotriene/betamethasone topical suspension is a topical therapy that is often used as monotherapy as a first-line treatment for plaque psoriasis. The objective of this preliminary, open label, single arm study was to determine the efficacy of adding a topical suspension to a traditional systemic therapy for psoriasis, either methotrexate or acitretin.In this exploratory study, eight patients with chronic plaque psoriasis who were on stable methotrexate or acitretin treatment without clearance were treated with once-daily calcipotriene/betamethasone topical suspension. Subjects completed five study visits over 12 weeks. Primary outcome measure was improvement of two or more points in Investigator Global Assessment. Secondary endpoints included change in Body Surface Area, Dermatology Life Quality Index, and Patient's Global Assessment from baseline to Week 12.Overall, the median decrease in Investigator Global Assessment over 12 weeks was 1.5 points, with 50 percent of subjects experiencing a drop of two or more points in Investigator Global Assessment. All eight subjects had a reduction in Body Surface Area and Patient's Global Assessment. There was a mean decrease in Dermatology Life Quality Index score of 78.9 percent, showing improved patient quality of life. In addition, all patients tolerated the treatment well and 6 of 8 patients had improved satisfaction level with their treatment by the end of the study.The topical suspension was effective and well-tolerated in conjunction with stable methotrexate or acitretin treatment in all eight patients in this study. These results support the feasibility of a larger scale study to further investigate the efficacy of these treatment combinations. The trial is registered at ClinicalTrials.gov, number NCT01761019." @default.
- W2509183933 created "2016-09-16" @default.
- W2509183933 creator A5023670588 @default.
- W2509183933 creator A5055816642 @default.
- W2509183933 creator A5060819284 @default.
- W2509183933 date "2016-04-01" @default.
- W2509183933 modified "2023-09-23" @default.
- W2509183933 title "A Preliminary, Open Label, Single-arm Study of Calcipotriene/Betamethasone Topical Suspension as a Supplement to Non-biologic Systemic Therapy for Psoriasis." @default.
- W2509183933 cites W106809472 @default.
- W2509183933 cites W1987367856 @default.
- W2509183933 cites W2046205521 @default.
- W2509183933 cites W2060086598 @default.
- W2509183933 cites W2063507100 @default.
- W2509183933 cites W2070835847 @default.
- W2509183933 cites W2098061970 @default.
- W2509183933 cites W2163031644 @default.
- W2509183933 cites W82563139 @default.
- W2509183933 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4898582" @default.
- W2509183933 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27462386" @default.
- W2509183933 hasPublicationYear "2016" @default.
- W2509183933 type Work @default.
- W2509183933 sameAs 2509183933 @default.
- W2509183933 citedByCount "0" @default.
- W2509183933 crossrefType "journal-article" @default.
- W2509183933 hasAuthorship W2509183933A5023670588 @default.
- W2509183933 hasAuthorship W2509183933A5055816642 @default.
- W2509183933 hasAuthorship W2509183933A5060819284 @default.
- W2509183933 hasConcept C126322002 @default.
- W2509183933 hasConcept C159110408 @default.
- W2509183933 hasConcept C16005928 @default.
- W2509183933 hasConcept C1862650 @default.
- W2509183933 hasConcept C2776173921 @default.
- W2509183933 hasConcept C2777011040 @default.
- W2509183933 hasConcept C2777501473 @default.
- W2509183933 hasConcept C2778496887 @default.
- W2509183933 hasConcept C2779800615 @default.
- W2509183933 hasConcept C2779951463 @default.
- W2509183933 hasConcept C2780564577 @default.
- W2509183933 hasConcept C2781059491 @default.
- W2509183933 hasConcept C2781162121 @default.
- W2509183933 hasConcept C71924100 @default.
- W2509183933 hasConceptScore W2509183933C126322002 @default.
- W2509183933 hasConceptScore W2509183933C159110408 @default.
- W2509183933 hasConceptScore W2509183933C16005928 @default.
- W2509183933 hasConceptScore W2509183933C1862650 @default.
- W2509183933 hasConceptScore W2509183933C2776173921 @default.
- W2509183933 hasConceptScore W2509183933C2777011040 @default.
- W2509183933 hasConceptScore W2509183933C2777501473 @default.
- W2509183933 hasConceptScore W2509183933C2778496887 @default.
- W2509183933 hasConceptScore W2509183933C2779800615 @default.
- W2509183933 hasConceptScore W2509183933C2779951463 @default.
- W2509183933 hasConceptScore W2509183933C2780564577 @default.
- W2509183933 hasConceptScore W2509183933C2781059491 @default.
- W2509183933 hasConceptScore W2509183933C2781162121 @default.
- W2509183933 hasConceptScore W2509183933C71924100 @default.
- W2509183933 hasIssue "4" @default.
- W2509183933 hasLocation W25091839331 @default.
- W2509183933 hasOpenAccess W2509183933 @default.
- W2509183933 hasPrimaryLocation W25091839331 @default.
- W2509183933 hasRelatedWork W2139483019 @default.
- W2509183933 hasRelatedWork W2598933245 @default.
- W2509183933 hasRelatedWork W2766413417 @default.
- W2509183933 hasRelatedWork W2900581149 @default.
- W2509183933 hasRelatedWork W3084498249 @default.
- W2509183933 hasRelatedWork W3112549804 @default.
- W2509183933 hasRelatedWork W4205675137 @default.
- W2509183933 hasRelatedWork W4213143336 @default.
- W2509183933 hasRelatedWork W4245009736 @default.
- W2509183933 hasRelatedWork W4252495384 @default.
- W2509183933 hasVolume "9" @default.
- W2509183933 isParatext "false" @default.
- W2509183933 isRetracted "false" @default.
- W2509183933 magId "2509183933" @default.
- W2509183933 workType "article" @default.